How is Cardiotoxicity Diagnosed and Managed?

How is Cardiotoxicity Diagnosed and Managed?

Oncology and cardiology teams can work closely together on providing care for people undergoing cancer treatment before problems arise. These “cardio-oncology” teams monitor patients at risk of developing heart problems during cancer therapy, diagnose any heart issues, and begin early treatment. These teams continue to monitor patients in the months and years following cancer treatment. Cardiotoxicity is diagnosed by physical exams and specific tests. 

I May Look the Same, But…

I May Look the Same, But…

December 8, 2009:  I hurried my dog along the sidewalk for a short walk before a lunch meeting with a colleague.  As we rounded the uphill corner of the street, I waved a hello to our mailman as we passed by. That was the last thing I remember.  Moments later, I opened my eyes to discover I was lying face down on the sidewalk, chin bleeding, and my dog waiting patiently at my side.  Within the hour, two ambulances arrived at our house, and my husband had rushed home.  I was taken to emergency and, once my chin was stitched up, hospitalized for three days of observation and tests.  On the third afternoon, a staff cardiologist appeared at my bedside: “It’s heart failure.”   

PWLE Engagement

PWLE Engagement

The voices and perspectives of patients, caregivers, and family members are essential to the work of the Ted Rogers Centre for Heart Research. This commitment is shared by the Peter Munk Cardiac Centre and by UHN as a whole.